Clinical applications of intravascular magnetic resonance contrast agents

Imaging Decisions MRI, Vol. 11, No. 4. (2008), pp. 19-25.

View FullText article

Blackwell Synergy, DOI, IngentaConnect

Reviews [Write a review of this article]

There are no reviews of this article

Notes for this article

sjakov has 0 private notes and 1 public note for this article.

Gadofosveset Trisodium (Vasovist) is a safe and well tolerated intravascular contrast agent, currently approved in Europe and Canada. It has proved to be effective in the asessment of vascular diseases at all vascular territories. The possibility to image at steady state opens new horizons by increasing the spatial resolution and the robustness of diagnostic MRA. Initial studies proved the possibility to image beyond the vascular territory and to assess enhancing lesions as known from studies with standard contrast agents.

sjakov (public note) - 2008-01-24 20:44:44

Find related articles from these CiteULike users

sjakov

Find related articles with these CiteULike tags

contrast, human, mri, vascular

@article{citeulike:2283309, author = {Essig and M.}, citeulike-article-id = {2283309}, comment = {Gadofosveset Trisodium (Vasovist) is a safe and well tolerated intravascular contrast agent, currently approved in Europe and Canada. It has proved to be effective in the asessment of vascular diseases at all vascular territories. The possibility to image at steady state opens new horizons by increasing the spatial resolution and the robustness of diagnostic MRA. Initial studies proved the possibility to image beyond the vascular territory and to assess enhancing lesions as known from studies with standard contrast agents. }, doi = {http://dx.doi.org/10.1111/j.1617-0830.2007.00108.x}, issn = {1433-3317}, journal = {Imaging Decisions MRI}, keywords = {contrast, human, mri, vascular}, number = {4}, pages = {19--25}, posted-at = {2008-01-24 20:44:44}, priority = {2}, publisher = {Blackwell Publishing}, title = {Clinical applications of intravascular magnetic resonance contrast agents}, url = {http://dx.doi.org/10.1111/j.1617-0830.2007.00108.x}, volume = {11}, year = {2008} }

RIS record

TY - JOUR ID - citeulike:2283309 L3 - citeulike-article-id:2283309 TI - Clinical applications of intravascular magnetic resonance contrast agents JF - Imaging Decisions MRI VL - 11 IS - 4 SP - 19 EP - 25 PB - Blackwell Publishing SN - 1433-3317 KW - contrast KW - human KW - mri KW - vascular N1 - Gadofosveset Trisodium (Vasovist) is a safe and well tolerated intravascular contrast agent, currently approved in Europe and Canada. It has proved to be effective in the asessment of vascular diseases at all vascular territories. The possibility to image at steady state opens new horizons by increasing the spatial resolution and the robustness of diagnostic MRA. Initial studies proved the possibility to image beyond the vascular territory and to assess enhancing lesions as known from studies with standard contrast agents. AU - Essig PY - 2008/// UR - http://dx.doi.org/10.1111/j.1617-0830.2007.00108.x ER -

RIS BibTeX